UC-San Francisco: New Hope for Progressive Supranuclear Palsy With Innovative Trial
September 04, 2024
September 04, 2024
SAN FRANCISCO, California, Sept. 4 (TNSres) -- The University of California San Francisco campus issued the following news release:
* * *
$75 million NIH grant could lead to the first effective drugs for a condition with few treatment options.
* * *
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder . . .
* * *
$75 million NIH grant could lead to the first effective drugs for a condition with few treatment options.
* * *
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder . . .